Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Non-Opioid Pain Patch Market 2017-2025 - Expected to Reach $5 Billion -

Research and Markets
Posted on: 07 Mar 18

The "Global Non-Opioid Pain Patch Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report has been added to's offering.

The global non-opioid pain patch market was valued at US$ 3.6 billion in 2016, and is expected to reach US$ 5 billion by 2025, expanding at a CAGR of 3.5% from 2017 to 2025.

Growing elderly population, increasing incidences of chronic and acute pain, rising opioid abuse and death from opioid overdose are the major drivers of the non-opioid pain patch market. Lower back-pain is the most common ailment followed by migraine or headache and neck pain. This rising prevalence of chronic pain is one of the major driver of non-opioid pain patch market. The increasing adoption of technologically advanced products, healthcare expenditure for R&D to develop innovative products boost up the growth of the non-opioid pain patch market. However, the lack of awareness in developing nations, demand of oral medication are few major challenges associated with the non-opioid pain patch market.

The market is classified on the basis of patch type and are classified below:

  • Lidocaine Patches
  • Diclofenac Patches
  • Capsaicin Patches
  • Methyl Salicylate Patches
  • Others

The market is further segmented on the basis of distribution channels and the sub-segments are as follows:

  • Hospital pharmacy
  • Retail pharmacy/Independent pharmacy
  • E-commerce/Online pharmacy

The hospital pharmacy hold the major market share, however retail pharmacy and online pharmacy are anticipated to face significant growth in forecasting periods.

The non-opioid pain patch market currently contains multiple companies having their products marketed. The manufacturers are developing new innovative products and the market is growing due to high adoption and accessibilities of these products.

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Global Non-Opioid Pain Patch Market Analysis

Chapter 4 Global Non-Opioid Pain Patch Market Analysis, by Patch Type

Chapter 5 Global Non-Opioid Pain Patch Market Analysis, by Distribution Channel Type

Chapter 6 Global Non-Opioid Pain Patch Market Analysis, by Geography

Chapter 7 Company Profiles

  • Teh Seng Pharmaceutical Mfg. Co., Ltd.
  • Endo Pharmaceuticals Inc.
  • Teikoku Seiyaku Co.
  • Allergan
  • Pfizer, Inc.
  • Hisamitsu Pharmaceutical Co. Inc.
  • GlaxoSmithKline plc.
  • Mylan N.V.
  • IBSA Institut Biochimque SA, Inc.
  • Acorda Therapeutics

For more information about this report visit

View source version on

Business Wire

Last updated on: 07/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.